Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myoclonic Epilepsy”

121 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 121 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06112275
What this trial is testing

A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome (Australia Only)

Who this might be right for
Dravet Syndrome
Encoded Therapeutics 4
Large-scale testing (Phase 3)Study completedNCT02926898
What this trial is testing

A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 87
Large-scale testing (Phase 3)Study completedNCT02091375
What this trial is testing

Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

Who this might be right for
EpilepsyDravet Syndrome
Jazz Pharmaceuticals 120
Large-scale testing (Phase 3)Ended earlyNCT04378075
What this trial is testing

Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy

Who this might be right for
Mitochondrial DiseasesDrug Resistant EpilepsyLeigh Disease+5 more
PTC Therapeutics 68
Not applicableUnknownNCT06504511
What this trial is testing

SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom

Who this might be right for
SCN1ADravet SyndromeEpilepsy
NHS Greater Glasgow and Clyde 400
Early research (Phase 1)Study completedNCT05873062
What this trial is testing

Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK

Who this might be right for
Myoclonus Epilepsies, Progressive
Autifony Therapeutics Limited 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT06706388
What this trial is testing

Personalized Antisense Oligonucleotide Therapy for A Single Participant With ATN1 Gene Mutation

Who this might be right for
Dentatorubral-Pallidoluysian Atrophy
n-Lorem Foundation 1
Large-scale testing (Phase 3)Ended earlyNCT03299842
What this trial is testing

Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 5
Testing effectiveness (Phase 2)Study completedNCT01118962
What this trial is testing

Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 39
Not applicableNo Longer AvailableNCT01835314
What this trial is testing

Compassionate Use of Stiripentol in Dravet Syndrome

Who this might be right for
Dravet Syndrome
University of Colorado, Denver
Post-approval studies (Phase 4)Active Not RecruitingNCT05044819
What this trial is testing

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Who this might be right for
Lennox Gastaut SyndromeDravet SyndromeTuberous Sclerosis Complex
Jazz Pharmaceuticals 154
Testing effectiveness (Phase 2)Study completedNCT03650452
What this trial is testing

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

Who this might be right for
EpilepsyDravet SyndromeLennox-Gastaut Syndrome
Takeda 141
Large-scale testing (Phase 3)Looking for participantsNCT04462770
What this trial is testing

EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Epygenix 150
Large-scale testing (Phase 3)Study completedNCT02224573
What this trial is testing

An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes

Who this might be right for
EpilepsyDravet SyndromeLennox-Gastaut Syndrome
GW Research Ltd 681
Post-approval studies (Phase 4)Not Yet RecruitingNCT06924827
What this trial is testing

Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex

Who this might be right for
Dravet Syndrome (DS)Lennox-Gastaut Syndrome (LGS)
Elizabeth Donner 25
Not applicableTemporarily pausedNCT04486768
What this trial is testing

International CDKL5 Registry

Who this might be right for
CDKL5 Deficiency Disorder (CDD)
University of Pennsylvania 500
Large-scale testing (Phase 3)Ended earlyNCT04485104
What this trial is testing

Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures

Who this might be right for
Seizure in Participants With Tuberous Sclerosis ComplexSeizure in Participants With Dravet SyndromeSeizure in Participants With Lennox-Gastaut Syndrome
Jazz Pharmaceuticals 3
Not applicableNo Longer AvailableNCT02239276
What this trial is testing

Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies

Who this might be right for
Dravet SyndromeEpileptic Encephalopathies Associated With SCN1A Mutations
Cook Children's Health Care System
Not applicableAvailableNCT06149663
What this trial is testing

Intermediate-Size Expanded Access Protocol (EAP) for LP352

Who this might be right for
Dravet SyndromeLennox Gastaut SyndromeDevelopmental and Epileptic Encephalopathies
Longboard Pharmaceuticals
Large-scale testing (Phase 3)Active Not RecruitingNCT06660394
What this trial is testing

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

Who this might be right for
Dravet Syndrome
Longboard Pharmaceuticals 96
Next Page